P
Pharmala Biotech Holdings Inc
CNSX:MDMA
Pharmala Biotech Holdings Inc
CNSX:MDMA
Price:
0.1
CAD
Market Closed
Market Cap:
CA$10.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pharmala Biotech Holdings Inc
CNSX:MDMA
|
CA |
|
Chenzhou City Jingui Silver Industry Co Ltd
SZSE:002716
|
CN |
|
Radius Gold Inc
XTSX:RDU
|
CA |
|
J
|
Jadi Imaging Holdings Bhd
KLSE:JADI
|
MY |
|
S
|
Sangbo Co Ltd
KOSDAQ:027580
|
KR |
|
Build King Holdings Ltd
HKEX:240
|
HK |
|
Skako A/S
CSE:SKAKO
|
DK |
|
I
|
Integrated Drilling Equipment Holdings Corp
OTC:IRIG
|
US |
Balance Sheet
Balance Sheet Decomposition
Pharmala Biotech Holdings Inc
Pharmala Biotech Holdings Inc
Balance Sheet Decomposition is not available for
Pharmala Biotech Holdings Inc
Pharmala Biotech Holdings Inc
Balance Sheet
Pharmala Biotech Holdings Inc
Pharmala Biotech Holdings Inc
Currency: CAD
| Aug-2021 | Aug-2022 | Aug-2023 | Aug-2024 | Aug-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
2
|
1
|
0
|
0
|
0
|
|
| Cash |
2
|
1
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
3
|
1
|
1
|
1
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
1
|
2
|
2
|
2
|
|
| Total Assets |
3
N/A
|
2
-17%
|
2
+4%
|
3
+20%
|
3
+18%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+206%
|
1
+143%
|
1
-11%
|
1
+5%
|
|
| Equity | ||||||
| Common Stock |
2
|
5
|
5
|
6
|
7
|
|
| Retained Earnings |
0
|
3
|
4
|
5
|
6
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
3
N/A
|
2
-28%
|
1
-27%
|
2
+43%
|
2
+24%
|
|
| Total Liabilities & Equity |
3
N/A
|
2
-17%
|
2
+4%
|
3
+20%
|
3
+18%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
83
|
83
|
86
|
92
|
107
|
|
Switch to:
Switch to:
See Also
Discover More
